Search Results for abbott laboratories (Corporate Dealmaker)

Advanced Search

Sort ByDate Relevance	Search InCorporate Dealmaker The entire Deal Blogs Network

12 result(s) displayed (1 - 12 of 12):

Disney, Microsoft, Abbott Labs win M&A awards (from Corporate Dealmaker)

On Wednesday and Thursday, The Deal was in conference mode, hosting panels of high-profile dealmakers on financial and corporate sides, doing post-panel video interviews and live-blogging. The two-day Deal Economy 2010 event was capped off in a packed room where strategic dealmakers received honors for their M&A work. Corporate...

Posted on November 20, 2009 11:58 AM

Credit Suisse names pharma acquisition targets (from Corporate Dealmaker)

Regarding biotech M&A, Credit Suisse Group AG (NYSE:CS) doesn't think there will be more megamergers in the next 12 to 18 months -- we could have told you that. CS did list, however, what it sees as smaller prime acquisition targets alongside possible suitors: Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) by Abbott...

Posted on September 18, 2009 12:29 PM

Yipes! CEOs conned by M&A bankers! (from Corporate Dealmaker)

Attention, acquisitive CEOs. That means you, Larry Ellison of Oracle Corp. (NASDAQ:ORCL), and you, Sam Palmisano of IBM Corp. (NYSE:IBM), and you, Miles White of Abbott Laboratories (NYSE:ABT). On Thursday MarketWatch columnist David Weidner noticed the recent stirrings in the M&A market, and he seized the moment to pull back...

Posted on September 18, 2009 6:00 AM

Medtronic, Abbott settle IP dispute (from Corporate Dealmaker)

Medtronic Inc. (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) have settled a long-running intellectual property dispute. Under terms of the deal, Medtronic will pay Abbott $400 million, and the companies have agreed not to sue one another over coronary stent systems or IP for at least 10 years. Medtronic also agreed to...

Posted on July 27, 2009 2:55 PM

From defense to offense (from Corporate Dealmaker)

Some corporate dealmakers look at the world today and see little but risk. A few, however, are already finding opportunity in the downturn. You'll find some thoughts on how companies think these issues through in the Corporate Dealmaker column in the Jan. 26 issue of The Deal magazine, available online...

Posted on January 27, 2009 2:25 PM

More proof of healthcare's strength in Abbott's earnings call (from Corporate Dealmaker)

If you're a regular reader of this blog, you know that while dealflow has sputtered in most industries, it's moving at a relatively healthy clip in healthcare. In the past few weeks, we've highlighted transactions by Abbott Laboratories, Pfizer Inc., Medtronic Inc., GlaxoSmithKline plc, Johnson & Johnson -- which on...

Posted on January 22, 2009 1:39 PM

Abbott CFO on pricing of Advanced Medical Optics deal (from Corporate Dealmaker)

Monday we called Abbott Laboratories' acquisition of Advanced Medical Optics Inc., a maker of laser eye surgery gear and other eye-care products, well timed. Here's what Abbott CFO Thomas Freyman had to say on that point in a conference call on the deal Monday, picked up from the transcript posted...

Posted on January 13, 2009 11:43 AM

Abbott's well-timed deal for Advanced Medical Optics (from Corporate Dealmaker)

Looking for examples of how the recession is creating opportunities for prepared, financially strong acquirers? Check out the deal Abbott Laboratories announced Monday morning to buy Advanced Medical Optics Inc. for nearly $2.8 billion including assumed debt. On one hand, the $22 per share price was a 149% premium to...

Posted on January 12, 2009 12:19 PM

And the winners are ... (from Corporate Dealmaker)

Ready for a little good news? Try this: It may be a little beleaguered, but there's still a real economy out there where companies make things like communications gear and medicine and jet engines. And even in a period when things like toxic credit default swaps and noxious structured investment...

Posted on December 1, 2008 9:43 AM

Healthcare: Abbott Laboratories (from Corporate Dealmaker)

As the Dow Jones Industrial Average plunges into oblivion and dismal corporate headlines are the daily norm, Abbott Laboratories quietly goes about its business, not making waves, doing what it does best -- operating a solid company built on dozens upon dozens of deals. The Abbott Park, Ill., maker of...

Posted on December 1, 2008 9:37 AM

Report from the awards luncheon (from Corporate Dealmaker)

Regular visitors to this site may recall that in September we launched a survey to identify the Most Admired Corporate Dealmakers in three key industry sectors: healthcare, information technology and industrial. Well, despite a few minor distractions in the financial markets since then, The Deal's readers came through for us and identified the companies doing the best work in M&A in those...

Posted on November 12, 2008 4:48 PM

Abbott: No big deals, maybe some opportunistic ones (from Corporate Dealmaker)

Major acquisitions aren't ahead for Abbot Laboratories, CEO Miles White told investors on a conference call Wednesday, according to this Reuters story. But that doesn't rule out what White described as "opportunistic" deals. In that department, White surely knows what he's talking about. In the epic 2005 battle between Johnson...

Posted on January 23, 2008 4:12 PM